The Double Burden: Deciphering Chronic Limb-Threatening Ischemia in End-Stage Renal Disease

Abstract

ObjectivesChronic Limb-Threatening Ischemia (CLTI) in patients with End-Stage Renal Disease (ESRD) poses significant challenges in clinical management due to its unique pathology and poor treatment outcomes. This review calls for a tailored classification and risk assessment for these patients to guide better revascularization choices with early minor amputation as a first-line strategy in advanced stages. MethodsThis review consolidates key findings from recent literature on CLTI in ESRD, focusing on disease mechanisms, treatment options, and patient outcomes. It evaluates the literature to clarify the decision-making process for managing CLTI in ESRD. ResultsCLTI in ESRD patients often results in worse clinical outcomes, such as non-healing wounds, increased limb loss, and higher mortality rates. While the literature reveals ongoing debates regarding the optimal revascularization method, recent retrospective studies and meta-analyses suggest potential benefits of Endovascular Treatment (EVT) over Open Bypass Surgery (OB) in reducing mortality and wound complications, with comparable Amputation-free Survival rates. ConclusionsThe selection of revascularization methods in ESRD patients with CLTI is complex, necessitating individualized strategies. The importance of early detection and timely intervention is critical to decelerate disease progression and improve revascularization outcomes. There is a shift in these treatments strategies towards less invasive endovascular procedures, acknowledging the limitations these patients face with open revascularization surgeries. Considering early minor amputations after revascularization could prevent worse consequences, reflecting a shift in the approach to managing CLTI in ESRD patients.